Literature DB >> 34260913

Mechanical load regulates bone growth via periosteal Osteocrin.

Haruko Watanabe-Takano1, Hiroki Ochi2, Ayano Chiba3, Ayaka Matsuo4, Yugo Kanai5, Shigetomo Fukuhara6, Naoki Ito7, Keisuke Sako3, Takahiro Miyazaki3, Kazuki Tainaka8, Ichiro Harada9, Shingo Sato10, Yasuhiro Sawada11, Naoto Minamino4, Shu Takeda12, Hiroki R Ueda13, Akihiro Yasoda14, Naoki Mochizuki15.   

Abstract

Mechanical stimuli including loading after birth promote bone growth. However, little is known about how mechanical force triggers biochemical signals to regulate bone growth. Here, we identified a periosteal-osteoblast-derived secretory peptide, Osteocrin (OSTN), as a mechanotransducer involved in load-induced long bone growth. OSTN produced by periosteal osteoblasts regulates growth plate growth by enhancing C-type natriuretic peptide (CNP)-dependent proliferation and maturation of chondrocytes, leading to elongation of long bones. Additionally, OSTN cooperates with CNP to regulate bone formation. CNP stimulates osteogenic differentiation of periosteal osteoprogenitors to induce bone formation. OSTN binds to natriuretic peptide receptor 3 (NPR3) in periosteal osteoprogenitors, thereby preventing NPR3-mediated clearance of CNP and consequently facilitating CNP-signal-mediated bone growth. Importantly, physiological loading induces Ostn expression in periosteal osteoblasts by suppressing Forkhead box protein O1 (FoxO1) transcription factor. Thus, this study reveals a crucial role of OSTN as a mechanotransducer converting mechanical loading to CNP-dependent bone formation.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone growth; CNP; Chondrocyte; Mechanical load; Osteoblast; Osteocrin; Periosteum

Mesh:

Substances:

Year:  2021        PMID: 34260913     DOI: 10.1016/j.celrep.2021.109380

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

Review 1.  Periosteal Skeletal Stem and Progenitor Cells in Bone Regeneration.

Authors:  Simon Perrin; Céline Colnot
Journal:  Curr Osteoporos Rep       Date:  2022-07-13       Impact factor: 5.163

Review 2.  Exerkines in health, resilience and disease.

Authors:  Lisa S Chow; Robert E Gerszten; Joan M Taylor; Bente K Pedersen; Henriette van Praag; Scott Trappe; Mark A Febbraio; Zorina S Galis; Yunling Gao; Jacob M Haus; Ian R Lanza; Carl J Lavie; Chih-Hao Lee; Alejandro Lucia; Cedric Moro; Ambarish Pandey; Jeremy M Robbins; Kristin I Stanford; Alice E Thackray; Saul Villeda; Matthew J Watt; Ashley Xia; Juleen R Zierath; Bret H Goodpaster; Michael P Snyder
Journal:  Nat Rev Endocrinol       Date:  2022-03-18       Impact factor: 47.564

Review 3.  Physiological and Pathophysiological Effects of C-Type Natriuretic Peptide on the Heart.

Authors:  Akihiro Yasoda
Journal:  Biology (Basel)       Date:  2022-06-14

4.  Metformin combats high glucose-induced damage to the osteogenic differentiation of human periodontal ligament stem cells via inhibition of the NPR3-mediated MAPK pathway.

Authors:  Yi-Lin Zhang; Fen Liu; Zhi-Bang Li; Xiao-Tao He; Xuan Li; Rui-Xin Wu; Hai-Hua Sun; Shao-Hua Ge; Fa-Ming Chen; Ying An
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

5.  Osteocrin ameliorates adriamycin nephropathy via p38 mitogen-activated protein kinase inhibition.

Authors:  Takaya Handa; Keita P Mori; Akira Ishii; Shoko Ohno; Yugo Kanai; Haruko Watanabe-Takano; Akihiro Yasoda; Takashige Kuwabara; Nobuyuki Takahashi; Naoki Mochizuki; Masashi Mukoyama; Motoko Yanagita; Hideki Yokoi
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.379

6.  Osteocrin, a bone-derived humoral factor, exerts a renoprotective role in ischemia-reperfusion injury in mice.

Authors:  Yoshihiko Nishiguchi; Yusuke Hata; Ryosuke Date; Daisuke Fujimoto; Shuro Umemoto; Tomoko Kanki; Hideki Yokoi; Keita P Mori; Takaya Handa; Haruko Watanabe-Takano; Yugo Kanai; Akihiro Yasoda; Yuichiro Izumi; Yutaka Kakizoe; Naoki Mochizuki; Masashi Mukoyama; Takashige Kuwabara
Journal:  Nephrol Dial Transplant       Date:  2022-02-25       Impact factor: 5.992

7.  Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy.

Authors:  Courtney M Mazur; Christian D Castro Andrade; Nicha Tokavanich; Tadatoshi Sato; Michael Bruce; Daniel J Brooks; Mary L Bouxsein; Jialiang S Wang; Marc N Wein
Journal:  iScience       Date:  2022-08-27

8.  Protocol for whole-mount X-gal staining combined with tissue clearing in embryo and adult mouse using CUBIC.

Authors:  Haruko Watanabe-Takano; Moe Fukumoto; Shigetomo Fukuhara; Naoki Mochizuki
Journal:  STAR Protoc       Date:  2022-01-20

9.  Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin.

Authors:  Jialiang S Wang; Tushar Kamath; Courtney M Mazur; Fatemeh Mirzamohammadi; Daniel Rotter; Hironori Hojo; Christian D Castro; Nicha Tokavanich; Rushi Patel; Nicolas Govea; Tetsuya Enishi; Yunshu Wu; Janaina da Silva Martins; Michael Bruce; Daniel J Brooks; Mary L Bouxsein; Danielle Tokarz; Charles P Lin; Abdul Abdul; Evan Z Macosko; Melissa Fiscaletti; Craig F Munns; Pearl Ryder; Maria Kost-Alimova; Patrick Byrne; Beth Cimini; Makoto Fujiwara; Henry M Kronenberg; Marc N Wein
Journal:  Nat Commun       Date:  2021-11-01       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.